GEMFIBROZIL
Generic: GEMFIBROZIL
Chartwell RXManufacturer
ORALRoute
GEMFIBROZILActive Substance
1993-09-27Original Approval
GEMFIBROZIL is FDA application ANDA074270, sponsored by CHARTWELL MOLECULES. Any recalls listed below come from FDA drug enforcement reports, and reaction counts are the number of FAERS adverse event reports that mention the drug and that reaction; a report does not prove the drug caused it.
Top Reported Reactions
1
NAUSEA
641 reports
2
FATIGUE
616 reports
3
DRUG INEFFECTIVE
592 reports
4
DIARRHOEA
549 reports
5
PAIN
504 reports
6
RHABDOMYOLYSIS
470 reports
7
ASTHENIA
456 reports
8
DIZZINESS
445 reports
9
RENAL FAILURE
440 reports
10
CHRONIC KIDNEY DISEASE
437 reports